ORLANDO, Fla. — Asthma is the most common cause of chronic cough in children, but it’s important to be aware of other differential diagnoses for those patients who have less common concerns, according ...

No one wants to be the person who can’t stop coughing. Not only is it uncomfortable on your throat, but it also draws angry stares from others in elevators, subway cars, and restaurants—especially ...

Chronic cough is a persistent and often debilitating condition defined as a cough lasting for more than eight weeks. This syndrome presents a significant clinical challenge worldwide due to its ...

Please provide your email address to receive an email when new articles are posted on . Study findings indicate that chronic cough might be hereditary. Parent productive cough was not linked to ...

For patients with type 2 diabetes, there is an association between glucagon-like peptide-1 receptor agonist (GLP-1 RA) use and chronic cough, according to a study published online Nov. 26 in JAMA ...

STATE COLLEGE, Pa. (WPVI) -- A cough is supposed to protect the lungs and windpipe from irritants. But coughs that go on and on can be annoying - or signs of bigger problems. Chronic coughs can have ...

Chronic cough is among the most common reasons for seeking medical care, with middle-aged women the group most affected. New studies also show that this condition appears to be a hereditary phenomenon ...

A new genetic study has identified neurological mechanisms as key drivers of chronic cough. The findings significantly advance our biological understanding of the condition, shedding light on ...

Are you an adult who is suffering from a long-standing cough that does not produce phlegm and stops as soon as you fall asleep? Has your cough failed to improve despite being treated with different ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Data were derived from Gallagher TJ, et al. JAMA ...

Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, ...